Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer
Clinical trial NCT03937895 · COMPLETED
Trial details
- NCT number
- NCT03937895
- Sponsor
- SMT bio Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-03
- Primary completion
- 2021-06-08
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.